Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • NATURE PODCAST

Audio long-read: How drugmakers can be better prepared for the next pandemic

Researchers race to develop new antiviral drugs.
By
  1. Elie Dolgin

    1. Elie Dolgin is a science journalist in Somerville, Massachusetts.

    View author publications

    You can also search for this author in PubMed  Google Scholar

  2. Benjamin Thompson
    View author publications

    You can also search for this author in PubMed  Google Scholar

You have full access to this article via your institution.

The race for antiviral drugs to beat COVID — and the next pandemic, read by Benjamin Thompson

Download MP3

Despite warnings, and a number of close calls, drugmakers failed to develop and stockpile drugs to fight a viral pandemic. Now, in the wake of SARS-CoV-2, they are pledging not to make the same mistake again.

Around the world, researchers are racing to develop drugs to target COVID-19, but also broad-spectrum antivirals that could be used to treat future viral threats.

This is an audio version of our feature: The race for antiviral drugs to beat COVID — and the next pandemic

Never miss an episode: Subscribe to the Nature Podcast on Apple Podcasts, Google Podcasts, Spotify or your favourite podcast app. Head here for the Nature Podcast RSS feed.

doi: https://doi.org/10.1038/d41586-021-01047-2

Subjects

Latest on:

Nature Careers

Jobs

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing

Search

Advanced search

Quick links